Trial Profile

Mie Study of Clopidogrel Low Responder in Atherothrombotic Disease Patients with/without Diabetes.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 25 Aug 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Clopidogrel (Primary)
Indications Cerebral infarction; Coronary disorders; Embolism and thrombosis
Focus Pharmacogenomic; Therapeutic Use
Acronyms McLORDD

Most Recent Events

23 Aug 2016 Status changed from active, no longer recruiting to completed.
16 Jun 2013 Planned End Date changed from 1 Mar 2013 to 30 May 2014 as reported by University Hospital Medical Information Network - Japan.
16 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com